Ontology highlight
ABSTRACT:
SUBMITTER: Sur D
PROVIDER: S-EPMC7019711 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
Sur Daniel D Havasi Andrei A Cainap Calin C Samasca Gabriel G Burz Claudia C Balacescu Ovidiu O Lupan Iulia I Deleanu Diana D AlexandruIrimie
Journal of clinical medicine 20200109 1
Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient's T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is then reintroduced into the patient's body to fight the resilient cancer cells. After exhibiting positive results in hematological malignancies, this therapy is being proposed for solid tumors like colorectal cancer. The clinical data of CAR T-cell therapy ...[more]